Cancer Research Communications

Published by: American Association for Cancer Research  

People

  1. Diaz
    Diaz
  2. Kelly
    Kelly
  3. Tap
    Tap
  4. Abou-Alfa
    Abou-Alfa
  5. Autio
    Autio
  6. Avutu
    Avutu
  7. Begg
    Begg
  8. Benhamida
    Benhamida
  9. Boland
    Boland
  10. Bradic
    Bradic

Groups

  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Sloan Kettering Institute Postdocs (7)
  4. GSK Faculty (5)
  5. Epidemiology and Biostatistics (4)
  6. Gastrointestinal Oncology Service (4)
  7. Graduate Medical Education (4)
  8. Human Oncology and Pathogenesis Program (4)
  9. Biostatistics Service (3)
  10. Center for Pancreatic Cancer Research (3)
Search Within
Formats
  1. Journal Article (20)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Sloan Kettering Institute Postdocs (7)
  4. GSK Faculty (5)
  5. Epidemiology and Biostatistics (4)
  6. Gastrointestinal Oncology Service (4)

More Groups

People
  1. Chelsea Nichols (2)
  2. Ciara Kelly (2)
  3. Luis Diaz (2)
  4. William Tap (2)
  5. Abhinita Mohanty (1)
  6. Alexander Drilon (1)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (8)
Publishers
  1. American Association for Cancer Research (20)

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diverse ERBB2/ERBB3 activating alterations and coalterations have implications for HER2/3-targeted therapies across solid tumors
    Journal Article

    Liu, D.; Jee, J.; Drilon, A.; Heilmann, A. M.; Allen, J. M.; Schrock, A. B.; Keller-Evans, R. B.; Li, B. T.
    Cancer Research Communications (2025)

    Fulltext@MSK | Save
  • Stanniocalcin 1 in patients with refractory colorectal cancer treated with regorafenib: A post hoc biomarker analysis of the TEXCAN and CORRECT trials
    Journal Article

    Vienot, A.; Vernerey, D.; Bouard, A.; Klajer, E.; Kim, S.; Tournigand, C.; Louvet, C.; Andre, T.; Rousseau, B.; Wespiser, M.; more...
    Cancer Research Communications (2025)

    Fulltext@MSK | Save
  • Deep learning predicts subtype heterogeneity and outcomes in luminal A breast cancer using routinely stained whole-slide images
    Journal Article

    Kurian, N. C.; Gann, P. H.; Kumar, N.; McGregor, S. M.; Verma, R.; Sethi, A.
    Cancer Research Communications (2025)

    Fulltext@MSK | Save
  • Secondary endpoint utilization and publication rate among phase III oncology trials
    Journal Article

    Beck, E. J.; Sherry, A. D.; Florez, M. A.; Kouzy, R.; Abi Jaoude, J.; Lin, T. A.; Miller, A. M.; Passy, A. H.; Kupferman, G. S.; Patel, R. R.; more...
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • Pain and its association with survival for Black and White individuals with advanced prostate cancer in the United States
    Journal Article

    Rencsok, E. M.; Slopen, N.; McManus, H. D.; Autio, K. A.; Morgans, A. K.; McSwain, L.; Barata, P.; Cheng, H. H.; Dreicer, R.; Gerke, T.; more...
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • Weakly supervised deep learning predicts immunotherapy response in solid tumors based on PD-L1 expression
    Journal Article

    Ligero, M.; Serna, G.; El Nahhas, O. S. M.; Sansano, I.; Mauchanski, S.; Viaplana, C.; Calderaro, J.; Toledo, R. A.; Dienstmann, R.; Vanguri, R. S.; more...
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • Impact of tumor-intrinsic molecular features on survival and acquired tyrosine kinase inhibitor resistance in ALK-positive NSCLC
    Journal Article

    Nakazawa, M.; Harada, G.; Ghanem, P.; Bubie, A.; Kiedrowski, L. A.; Murray, J. C.; Marrone, K. A.; Scott, S. C.; Houseknecht, S.; Falcon, C. J.; more...
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • A phase I study of KIN-3248, an irreversible small-molecule pan-FGFR inhibitor, in patients with advanced FGFR2/3-driven solid tumors
    Journal Article

    Garmezy, B.; Borad, M. J.; Bahleda, R.; Perez, C. A.; Chen, L. T.; Kato, S.; Oh, D. Y.; Severson, P.; Tam, B. Y.; Quah, C. S.; more...
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • CALGB 80802 (Alliance): Impact of sorafenib with and without doxorubicin on hepatitis C infection in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Kumthekar, P.; Jacobson, S.; El Dika, I.; Yaqubie, A.; Lopez, J.; more...
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • Artificial intelligence-assisted cancer status detection in radiology reports
    Journal Article

    Arya, A.; Niederhausern, A.; Bahadur, N.; Shah, N. J.; Nichols, C.; Chatterjee, A.; Philip, J.
    Cancer Research Communications (2024)

    Fulltext@MSK | Save

    • Cancer Research Communications – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research Communications 27679764 The Authors Published
    Cancer Research Communications Unknown
    Cancer research communications 27679764 The Authors the American Association for Cancer Research
    Cancer Research Communications American Association for Cancer Research
    Cancer Research Communications 2767-9764 American Association for Cancer Research